Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -21.75% | 4.21bn |
Karuna Therapeutics Inc | -20.18% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -26.94% | 350.00m |
Mirati Therapeutics Inc | -27.79% | 5.12bn |
Data delayed at least 15 minutes, as of Jun 18 2024 16:15 BST.
Holder | Shares | % Held |
---|---|---|
Credit Suisse Asset Management (Schweiz) AGas of 31 Dec 2023 | 32.30k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 29 Feb 2024 | 6.84k | 0.00% |
Data from 29 Feb 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.